GL1X · GenesisL1 explorer

MolNFT v1 · #65248 · protein

Crystal structure of the F87M/L110M mutant of human transthyretin at pH 7.5

3GRG: “Crystal structure of the F87M/L110M mutant of human transthyretin at pH 7.5”. X-ray diffraction, 1 ligand (ZN), 7 pockets (best druggability 0.57). MolNFT v1 #65248 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3GRG
Type
protein
Length
461 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
ZN
Pockets
7 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 3% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1163% helix, 52% strandP02766
B, D, CTransthyretinprotein1153% helix, 52% strandP02766

Ligands and binding sites

  • ZN · Zinc ion · metal · 12 copies · chains A, B, D, C
  • ACT · Acetate ion · additive · 7 copies · chains A, B, D, C
  • GOL · Glycerol · additive · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11980.570.8034empty
22160.530.7735empty
31350.490.7929ACT
4770.340.7519empty
5700.340.7617empty

Interfaces

6 interfaces between chains.

  • A–B · 837 Ų buried · 22 hydrogen bonds · protein-protein
  • D–C · 829 Ų buried · 20 hydrogen bonds · protein-protein
  • B–D · 517 Ų buried · 5 hydrogen bonds · protein-protein
  • A–C · 481 Ų buried · 5 hydrogen bonds · protein-protein
  • A–D · 467 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 3GRG · Crystal structure of the F87M/L110M mutant of human transthyretin at pH 7.5 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.